CAMPBELL NEWMAN ASSET MANAGEMENT INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAMPBELL NEWMAN ASSET MANAGEMENT INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,331,627
+20.3%
48,876
-1.7%
0.13%
+27.3%
Q2 2023$1,106,648
+5.0%
49,737
+2.2%
0.10%
-2.9%
Q1 2023$1,053,651
+7.7%
48,645
+1.0%
0.10%
+5.2%
Q4 2022$978,658
-18.2%
48,186
+3.3%
0.10%
-28.1%
Q3 2022$1,196,000
+10.4%
46,658
+2.5%
0.14%
+17.4%
Q2 2022$1,083,000
+10.4%
45,542
+4.5%
0.12%
+22.3%
Q1 2022$981,000
+16.0%
43,568
+2.0%
0.09%
+25.3%
Q4 2021$846,000
+3.3%
42,722
+2.7%
0.08%
-10.7%
Q3 2021$819,000
-5.5%
41,596
+5.5%
0.08%
-1.2%
Q2 2021$867,000
-2.6%
39,419
+5.4%
0.08%
-9.6%
Q1 2021$890,000
-4.5%
37,407
+5.0%
0.09%
-11.3%
Q4 2020$932,000
+62.4%
35,637
+8.1%
0.11%
+43.2%
Q3 2020$574,000
+5.5%
32,955
+1.9%
0.07%
-1.3%
Q2 2020$544,000
+42.8%
32,344
+0.9%
0.08%
+15.4%
Q1 2020$381,000
-6.2%
32,040
-4.6%
0.06%
+18.2%
Q4 2019$406,000
-14.5%
33,580
-0.2%
0.06%
-19.1%
Q3 2019$475,000
+25.7%
33,633
-0.8%
0.07%
+23.6%
Q2 2019$378,000
+1.9%
33,904
+7.2%
0.06%
-3.5%
Q1 2019$371,000
-10.0%
31,637
+2.6%
0.06%
-20.8%
Q4 2018$412,000
+6.5%
30,822
+11.8%
0.07%
+28.6%
Q3 2018$387,00027,5740.06%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders